Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
0.9051
-0.0082 (-0.90%)
Jun 4, 2025, 1:47 PM - Market open

Sutro Biopharma Stock Forecast

STRO's stock price has decreased by -77.8% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 6 professional analysts, the 12-month price target for Sutro Biopharma stock ranges from a low of $0.80 to a high of $15. The average analyst price target of $5.47 forecasts a 504.35% increase in the stock price over the next year.

Price Target: $5.47 (+504.35%)
Analyst Consensus: Hold
Target Low Average Median High
Price $0.80 $5.47 $2.00 $15
Change -11.61% +504.35% +120.97% +1557.3%

Analyst Ratings

The average analyst rating for Sutro Biopharma stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 331111
Buy 442211
Hold 003444
Sell 001111
Strong Sell 000000
Total 777877

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
B of A Securities
B of A Securities
Sell
Maintains
$1$0.8
Sell Maintains $1$0.8 -11.61% May 19, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
$2
Hold Reiterates $2 +120.97% Apr 29, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
$12$2
Hold Downgrades $12$2 +120.97% Mar 17, 2025
Citizens Capital Markets
Citizens Capital Markets
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Mar 14, 2025
Wedbush
Wedbush
Hold
Downgrades
$8$2
Hold Downgrades $8$2 +120.97% Mar 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
56.20M
from 62.04M
Decreased by -9.42%
Revenue Next Year
47.00M
from 56.20M
Decreased by -16.37%
EPS This Year
-1.88
from -2.96
EPS Next Year
-1.28
from -1.88
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
42.72M61.88M67.77M153.73M62.04M56.20M47.00M61.27M
Revenue Growth
-0.03%44.84%9.52%126.84%-59.64%-9.42%-16.37%30.36%
EPS
-0.99-2.29-2.35-1.78-2.96-1.88-1.28-1.41
EPS Growth
--------
Forward PE
--------
No. Analysts
-----131311
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 79.7M 83.4M 169.5M
Avg 56.2M 47.0M 61.3M
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High
28.5%
48.3%
260.6%
Avg
-9.4%
-16.4%
30.4%
Low - - -

EPS Forecast

EPS 20252026202720282029
High -1.12 -0.21 -0.18
Avg -1.88 -1.28 -1.41
Low -2.81 -2.29 -2.12

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.